z-logo
open-access-imgOpen Access
A Paternally InheritedBRCA1Mutation Associated with an Unusual Aggressive Clinical Phenotype
Author(s) -
Florentia Fostira,
Nikolaos Tsoukalas,
Irene Konstantopoulou,
V. Georgoulias,
Charalambos Christophyllakis,
Drakoulis Yannoukakos
Publication year - 2014
Publication title -
case reports in genetics
Language(s) - English
Resource type - Journals
eISSN - 2090-6544
pISSN - 2090-6552
DOI - 10.1155/2014/875029
Subject(s) - penetrance , medicine , breast cancer , mutation , exon , phenotype , triple negative breast cancer , genetic counseling , family history , disease , genetics , lung cancer , cancer , gene , cancer research , oncology , biology
This report highlights the necessity of genetic testing, at least for BRCA1 mutations, of young females diagnosed with triple negative breast cancer, even in the absence of or limited family history. A 34-year-old female with a locally advanced, triple negative tumour, which perforated the skin, is described. At the time of diagnosis, the patient had already multiple lung metastases and although chemotherapy was started immediately, she died with rapid systemic disease progression. The patient was found to carry the BRCA1 p.E1060X mutation, which is located on exon 11 of the gene. The high penetrance of BRCA1 gene is not represented in the patient's family, since the mutation was paternally inherited. It is evident that females belonging to small families, along with paternal inheritance of pathogenic BRCA mutations that predispose for breast cancer, in most cases will probably be genetically tested only after being diagnosed with cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom